The FTC is expanding its ongoing study on pharmacy benefit managers (PBMs) and their impact on the accessibility and affordability of prescription drugs
The increase in drug prices has increased the attention on PBMs, and the role they play in drug pricing, both at the federal and state levels
AMI’s new report, Primary Care Providers: Evolving in 2023-2024 provides a background of the primary care market and profiles the companies that will be leading the market in 2023 and beyond
AMI has recently published BusIntell Reports on 10 of the leading companies transforming the healthcare market.
Optum Specialty Fusion™ was launched to streamline treatment decision-making for care providers, helping patients get on their therapies faster
Sutter Health Plus is changing its PBM to CVS Caremark® from Express Scripts®. CVS Caremark will manage the pharmacy benefits for its approximately 100,000 members
Point32Health entered into a new, multi-year agreement with OptumRx to provide integrated Pharmacy Benefit Management (PBM) solutions that will enhance services and deliver improved pricing for Harvard Pilgrim and Tufts Health Plan members
Optum Frontier Therapies Centers of Excellence (COEs) consist of dedicated teams focused on cell and gene therapy, rare disease drugs and digital therapeutics